Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Translation of genomics into routine cardiological practice: insights from a European Society of Cardiology Cardiovascular Round Table

19 Feb 2025

Abstract excerpt

Cardiovascular diseases (CVD) remain the leading cause of death globally and there is an urgent need for innovative approaches to treatment. One emerging avenue is genetic therapies, which hold particular promise for diseases with a monogenic basis. Gene silencing techniques using antisense oligonucleotides or ribonucleic acid interference strategies are currently at the forefront of genetic therapies in CVD,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis: Diagnosis, Treatment, Outcomes
Share to Cardiomyopathy and Myosin Studies
Share to Protein Kinase Regulation and GTPase Signaling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39969133
DOI: 10.1093/eurheartj/ehaf041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Translation of genomics into routine cardiological practice: insights from a European Society of Cardiology Cardiovascular Round TablePMID 39969133Read ↗

Advances in nucleic acid-targeted therapies for cardiovascular disease preventionSemantic proximity Read ↗

Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart AssociationSemantic proximity Read ↗

Gene therapy and genome editing for lipoprotein disordersSemantic proximity Read ↗

A genomic revolution for cardiovascular disease-a progress report at five years.Semantic proximity Read ↗

Gene-based therapy in lipid management: the winding road from promise to practiceSemantic proximity Read ↗

Precision Medicine in Cardiovascular Disease: Genetics and Impact on Phenotypes: JACC Focus Seminar 1/5.Semantic proximity Read ↗

CRISPR and cardiovascular diseasesSemantic proximity Read ↗

A New Era of Disease‐Modifying Pharmacotherapy in Cardiovascular MedicineSemantic proximity Read ↗

Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.Semantic proximity Read ↗

State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial DiseasesSemantic proximity Read ↗

Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association.Semantic proximity Read ↗

Gene editing therapy for cardiovascular diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.